文献速递免疫规划妇幼与学校卫生营养与食品安全

尼泊尔农村地区孕产妇流感免疫接种后六月龄婴儿营养状况:一项随机安慰剂对照试验

Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal.
PubMed 文献 · Vaccine · 2017-10-31

在尼泊尔农村开展随机安慰剂对照试验,3693名孕17–34周女性接种流感疫苗或安慰剂,所生3646名活产儿在6月龄测量体格指标。疫苗组与安慰剂组相比,低出生体重减少15%,但6月龄仅第二队列的消瘦差异有统计学意义,研究对检测公共卫生重要性的降低效力不足。

要点

  • 孕产妇流感免疫接种使低出生体重减少15%。
  • 6月龄消瘦在第二队列疫苗组较安慰剂组有统计学显著差异,第一队列无显著差异。
  • 研究对检测6月龄发育迟缓与消瘦的公共卫生重要性降低效力不足。

核心结论

  • 孕产妇免疫接种使低出生体重减少15%,但6月龄仅第二队列的消瘦差异有统计学意义,研究对检测公共卫生重要性的降低效力不足。

研究设计与样本

  • 在尼泊尔南部平原萨拉希区两个年度队列中开展的全年孕产妇流感免疫接种随机安慰剂对照试验,2011年4月至2014年4月进行。
  • 3693名孕17–34周女性接受安慰剂或流感疫苗,共3646名活产儿,在出生时和6月龄测量体重、身长和头围。
  • 研究把握度针对3个主要试验结局,而非6月龄发育迟缓和消瘦。

主要发现

  • 6月龄存活婴儿中约72%在150–210日龄间有体重和身长测量。
  • 发育迟缓(年龄别身长Z评分<-2)安慰剂组14.8% vs 疫苗组13.6%。
  • 严重发育迟缓(年龄别身长Z评分<-3)安慰剂组3.2% vs 疫苗组2.0%(RR 0.64,95%CI 0.39–1.04)。
  • 消瘦(身长别体重Z评分<-2)安慰剂组10.3% vs 疫苗组11.0%;严重消瘦(身长别体重Z评分<-3)安慰剂组3.8% vs 疫苗组2.6%(RR 0.69,95%CI 0.44–1.07)。
  • 流感疫苗对消瘦的影响第二队列大于第一队列:任何消瘦RR 0.66(95%CI 0.44–0.99),严重消瘦RR 0.45(95%CI 0.19–1.09),对应第二队列出生体重影响更大且疫苗与流行病毒匹配更好。

局限性

  • 研究把握度针对3个主要试验结局,而非6月龄发育迟缓和消瘦。
  • 研究对检测公共卫生重要性的降低效力不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal influenza vaccination has increased birth weight in two randomized trials in South Asia but the impact on infant growth is unknown. METHODS: A randomized placebo-controlled trial of year round maternal influenza immunization was conducted in two annual cohorts in Sarlahi District, southern plains of Nepal, from April 2011 through April 2014. Infants born to women enrolled in the trial had weight, length, and head circumference measured at birth and 6 months of age. The study was powered for the 3 primary trial outcomes but not for stunting and wasting at 6 months of age. RESULTS: 3693 women received placebo or influenza vaccine between 17 and 34 weeks gestation, resulting in 3646 live births. About 72% of infants who survived had weight and length measurements between 150 and 210 days of age. Prevalence of stunting (<-2 Z scores length-for-age) was 14.8% in the placebo and 13.6% in the vaccine groups, respectively. Stunting < -3 Z scores was 3.2% versus 2.0% in placebo versus vaccine groups (RR: 0.64 (95% CI: 0.39, 1.04)). Wasting (< -2 Z scores weight for length) was 10.3% versus 11.0% for placebo versus vaccine groups. Severe wasting (< -3 Z scores weight for length) was 3.8% for placebo versus 2.6% for vaccine (RR: 0.69 (95% CI: 0.44, 1.07)). The impact of flu vaccine on wasting was greater in cohort 2 than in cohort 1, (RR: 0.66 (0.44, 0.99) for any wasting), and RR: 0.45 (0.19, 1.09) for severe wasting. This corresponded to a larger impact on birth weight and a better vaccine match with circulating viruses in cohort 2. CONCLUSIONS: Although maternal immunization reduced low birth weight by 15%, only wasting at 6 months in the 2nd cohort was statistically significantly difference. However, the study was underpowered to detect reductions of public health importance. TRIAL REGISTRATION: Clinicaltrials.gov (NCT01034254).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Katz J, Englund JA, Steinhoff MC, et al. Nutritional status of infants at six months of age following maternal influenza immunization: A randomized placebo-controlled trial in rural Nepal. Vaccine. 2017. PMID: 29100709. doi:10.1016/j.vaccine.2017.09.095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。